Atypical hemolytic uremic syndrome (aHUS), caused by hyperactivation of the alternative complement pathway, is a typical disorder, with inherited or acquired abnormalities of complement pathway proteins present in approximately 60% of patients. Here, Creative Biolabs has developed the CFH genetic and acquired abnormalities functional analysis protocol. The underlying complement deficiency in aHUS can be characterized based on the patient's plasma or serum.
CFH Genetic and Acquired Abnormalities Functional Analysis Protocol
Fig.1 Flow chart of the CFH genetic and acquired abnormalities functional analysis protocol. (Creative Biolabs)
To provide assistance to the research of the human complement system and related diseases to the greatest extent, Creative Biolabs has developed a series of protocols to meet various needs. We are pleased to use our extensive experience and advanced platform to offer the best service and the most qualified products to satisfy each demand from our customers. On the basis of the standard protocol, we can also optimize it to meet the special needs of customers.
To learn more details, you can get access with the following links:
If you are interested in our services and products, please do not hesitate to contact us for more information.
For Research Use Only.
Related Sections:
